Wedbush Securities’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Wedbush Securities's AQST Position: Q3 2026 in Review
Wedbush Securities increased its Aquestive Therapeutics (AQST) stake by 1.4% in Q3 2026, buying an estimated $889 and bringing the position to 14,700 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.
Wedbush Securities first reported a position in AQST in Q2 2019 and has held it in 10 quarters since. The position peaked at $665K in Q2 2020. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Wedbush Securities held 14,700 shares of Aquestive Therapeutics worth $68K as of Q3 2026.
- Wedbush Securities bought 200 Aquestive Therapeutics shares in Q3 2026, an estimated $889.
- Aquestive Therapeutics made up ﹤0.01% of Wedbush Securities's portfolio in Q3 2026, its #1273 holding.
- Wedbush Securities first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 10 quarters since.
- Wedbush Securities's Aquestive Therapeutics position peaked at $665K in Q2 2020.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Wedbush Securities's 13F filing for Q3 2026, filed 22 Oct 2026.